Meeting
2022 ASCO Annual Meeting
Machine learning (ML)–enabled, circulating tumor cell–based classification of patients for non-prerequisite adjuvant therapy.
Authors
Gowhar Shafi
Indx Technology, Mumbai, India
Gowhar Shafi , Aarthi Ramesh , Krithika Srinivasan , Atul Bharde , Burhanuddin Qayyumi , Gourishankar Aland , Sreeja Jayant , Alain D'Souza , Aravindan Vasudevan , Mohan Uttarwar , Pankaj Chaturvedi , Jayant Khandare
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Care Delivery and Regulatory Policy
Track
Care Delivery and Quality Care
Sub Track
Clinical Informatics/Advanced Algorithms/Machine Learning
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 1547)
DOI
10.1200/JCO.2022.40.16_suppl.1547
Abstract #
1547
Poster Bd #
140
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Genitourinary Cancers Symposium
Development of a novel machine learning-based predictive risk calculator for radical cystectomy.
First Author: Aravind Rajagopalan
Poster
2023 ASCO Annual Meeting
Association of social vulnerability with delays in starting guideline-adherent adjuvant therapy among patients with head and neck cancer.
First Author: Joshua Lee Cagle
Poster
2022 ASCO Quality Care Symposium
Physician referral patterns and use of adjuvant therapy among patients with stage IB-IIIA non–small cell lung cancer (NSCLC) (2010-2017).
First Author: Hrishikesh Kale
Poster
2017 ASCO Annual Meeting
PREDICTOR (UNICANCER GEP11): Randomized phase II study of preoperative afatinib in untreated head and neck squamous cell carcinoma (HNSCC) patients.
First Author: Christophe Le Tourneau